4 results about "Depigmentation" patented technology

The present invention relates to a composition comprising cysteamine, azabenzene-4-carboxamide and glycolic acid. The present invention also relates to the cosmetic use thereof for inhibiting, reducing or preventing skin pigmentation and to the therapeutical use thereof for inhibiting, reducing or preventing skin hyperpigmentation diseases or disorders.

The present invention relates to a nutritional and health care composition for oral administration, comprising an extract of Glycyrrhiza glabra L. and an extract of Olea eupaea L.. The nutritional and health care composition is characterized in that the nutritional and health care composition comprises an extract of Glycyrrhiza glabra L. and an extract of Olea eupaea L.. The formulations are suitable for use as skin decolorizing and bleaching agents and for controlling skin protein saccharification.

The present invention relates to a whitening composition comprising a whitening effective amount of a compound of formula (I), or a tautomer, stereoisomer, hydrate, solvate, salt, or polymorph thereof, wherein R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、R 7 、m and n are as defined in the specification and claims. The present invention also relates to a compound of formula (I2) or a tautomer, stereoisomer, hydrate, solvate, salt, or polymorph thereof, wherein R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、and R 7 are as defined in the specification and claims. The present invention also relates to the use of at least one compound of formula (I) or any subgroup thereof, or a mixture thereof, as a depigmenting agent. The present invention also relates to the use of at least one compound of formula (I) or any subgroup thereof, or the use of a whitening composition, for preventing and / or reducing pigmentation of normal skin. The present invention also relates to the use of at least one compound, or the use of a whitening composition according to the first aspect, for reducing the amount of melanin in melanocytes, for reducing melanin synthesis, for impairing melanin transport, and / or for impairing the distribution of melanin in the upper basal layer. JPEG2026520910000038.jpg3191

The invention provides application of apocynin in preparation of a medicine for preventing and / or treating depigmentation skin diseases, and belongs to the technical field of skin disease medicine manufacturing. The invention discloses application of apocynin or an apocynin derivative in preparation of a medicine for preventing and / or treating depigmentation skin diseases, especially vitiligo. The medicine prepared from the apocynin can effectively recover leucoderma model mouse skin pigments, effectively reduce expression of model mouse skin inflammatory factors and reduce infiltration of CD8 + T cells. Therefore, the apocynin or the apocynin derivative achieves the purpose of treating depigmentation skin diseases by relieving skin inflammation, protecting melanocytes from being oxidized and damaged and promoting melanogenesis. The invention not only expands the medical application of apocynin, but also provides a new way for clinical treatment of depigmentation dermatosis.